This site is optimised for modern browsers. For the best experience, please use Google Chrome, Mozilla Firefox, or Microsoft Edge.

Research and Innovation for Global Health Transformation - Call 1 Stage 1 Minutes

Contents

Minutes of the Research and Innovation for Global Health Transformation (RIGHT) Programme Funding Committee Meeting for Call 1 Stage 1

Date and location

The meeting held on 19 October 2018 by webinar.

In attendance

Funding Committee Members 

Professor Tom Solomon (Chair)
Dr Marie-Paule Kieny (Deputy Chair)
Professor Pamela Abbott
Dr Mary AmauyunzuNyamongo
Professor Ben Anderson 
Professor Marcello Barcinski
Professor Kalipso Chalkidou
Professor Lara Fairall
Professor Elizabeth Grant
Professor Li Yang Hsu 
Professor Moffat Nyirenda 
Dr David Phipps 
Dr Paul Saunderson

Apologies

Professor Hermann Feldmeier (provided written comments)
Professor Pierre-Marie Preux (provided written comments) 
Professor Janaka da Silva (provided written comments)

Secretariat

Dr Mike Rogers (NIHR CCF)
Dr Debbie Willis (NIHR CCF)
Dr Nicola Commander (NIHR CCF)
Ms Daniela Toale (NIHR CCF)
Mr Bryan Dar (NIHR CCF)
Ms KatalinTorok (NIHR CCF)

Observing

Mr David Chandler (Public Member)
Ms Una Rennard (Public Member)
Ms Laurence Poos (DHSC)
Ms Alison MacEwen (DHSC)
Dr Alex Ademokun (DHSC)

RIGHT Call 1 Stage 1 applications considered

NIHR200097: Improving the access to and delivery of epilepsy care in India and Uganda as exemplars of low and middle income countries (IDEAL)
Conflicts: Professor Tom Solomon
Outcome: Reject

NIHR200124: Sustainable Treatment, Reducing Access Barriers and Promoting Participation in Epilepsy (STRAPP) 
Conflicts: None
Outcome: Reject

NIHR200125: Improving experiences of severe stigmatising skin diseases in Ghana and Ethiopia
Conflicts: Dr Paul Saunderson, Professor Moffat Nyirenda
Outcome: Invite to Stage 2

NIHR200126: Reducing the prevalence of hepatocellular carcinoma by preventing mother to child transmission of hepatitis B: A double-blind, randomised, placebocontrolled trial of tenofovir disoproxil fumarate
Conflicts: Professor Marcello Barcinski
Outcome: Reject

NIHR200127: REducing Stigmatising skin cOnditions prevaLent in Vietnamese amputEes; RESOLVE
Conflicts: Professor Kalipso Chalkidou
Outcome: Reject

NIHR200128: Towards elimination of hepatitis B elimination in Africa: the Intervention for Avoidance of Neonatal Transmission of hepatitis B in Africa (INFANT-B) study.
Conflicts: Professor Kalipso Chalkidou
Outcome: Reject

NIHR200129: REDRESS: Reducing the Burden of Severe Stigmatising Skin Diseases through equitable person-centred approaches to health systems strengthening
Conflicts: Dr Paul Saunderson
Outcome: Invite to Stage 2

NIHR200130: Improving diagnostic and treatment regimes for HIV-associated Kaposi’s sarcoma patient outcome
Conflicts: None
Outcome: Reject

NIHR200131: Using lab-on-a-chip solutions to reduce deaths caused by EBVpositive nasopharyngeal cancer - a proof of principle approach for improving cancer outcomes in the Global South
Conflicts: Professor Kalipso Chalkidou
Outcome: Reject

NIHR200132: Transforming the Treatment and Prevention of Leprosy and Buruli ulcers in Low and Middle-Income Countries (LMICs)
Conflicts: Dr Paul Saunderson, Professor Kalipso Chalkidou, Professor Tom Solomon
Outcome: Invite to Stage 2

NIHR200133: Evaluation and Transfer of mobile whole slide tissue scanners and liquid biopsies to deliver fast and precise diagnosis for improved outcomes of children and young adults with EBV-driven lymphoma: a joint Tanzanian and Ugandan Paediatric Oncology Network Initiative
Conflicts: None
Outcome: Invite to Stage 2

NIHR200134: Epilepsy in vulnerable populations of sub-Saharan Africa
Conflicts: Professor Pierre-Marie Preux
Outcome: Shortlisted to Stage 2

NIHR200135: ECLIPSE (Empowering Cutaneous Leishmaniasis patients: an Intervention Programme to reduce time to treatment and Stigma via community Education).
Conflicts: None
Outcome: Invite to Stage 2

NIHR200136: Reducing cutaneous Leishmaniasis in Ethiopia
Conflicts: Professor Liz Grant
Outcome: Reject

NIHR200137: EN-EPILEPSIES Every Newborn - Epilepsy Prevention In LMIC, Enhancing care, Parent Support & Impairment Evaluation Study 
Conflicts: Professor Moffat Nyirenda, Professor Pierre-Marie Preux
Outcome: Invite to Stage 2

NIHR200138: Improving the detection and management of Burkitt lymphoma in subSaharan Africa and beyond
Conflicts: Professor Tom Solomon
Outcome: Invite to Stage 2

NIHR200139: Innovative approaches to informing policy and guidance– multidimensional strategies that develop an evidence base around scabies in Brazil, Ghana and Papua New Guinea
Conflicts: None
Outcome: Reject

NIHR200140: Social Sciences for Severe Stigmatising Skin Diseases (the 5-S Foundation)
Conflicts: None
Outcome: Invite to Stage 2

NIHR200141: STARS - Strengthening Treatment, Access and Response to epilepsy in South America
Conflicts: Professor Pierre-Marie Preux
Outcome: Reject

NIHR200142: Comprehensive assessment of host and pathogen determinants of infection-related cancers in a large prospective study in China
Conflicts: None
Outcome: Reject

NIHR200143: Reducing the burden of Kaposi’s sarcoma and Burkitt lymphoma in sub-Saharan Africa.
Conflicts: Professor Moffat Nyirenda
Outcome: Invite to Stage 2

NIHR200144: Prevention of epilepsy from birth-related brain injury
Conflicts: Professor Kalipso Chalkidou
Outcome: Invite to Stage 2

NIHR200145: Biomarkers for Sensing Human Skin Cell Reprogramming in Response to Mycobacterium leprae As Early Diagnosis for Leprosy: Direct Implementation in LMICs 
Conflicts: Professor Liz Grant
Outcome: Reject

NIHR200146: Epilepsy in Children in East Africa; Aetiology, Co-morbidities and Seizure Outcomes
Conflicts: Professor Pierre-Marie Preux
Outcome: Invite to Stage 2

NIHR200147: Epstein Barr virus and human Herpesvirus 8 associated lymphomas and lymphoproliferative disorders in Africa – to achieve improved diagnosis and management, and better understanding of aetiopathogenesis.
Conflicts: Professor Kalipso Chalkidou
Outcome: Invite to Stage 2